Monday, May 11, 2020

[ASAP] Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities

TOC Graphic

ACS Nano
DOI: 10.1021/acsnano.0c02633


from ACS Nano: Latest Articles (ACS Publications) https://ift.tt/2WnMNWa
via IFTTT

No comments:

Post a Comment